Business Context and Reporting Period
This Form 8-K, filed on May 10, 2013, reports that Flotek Industries, Inc. completed the acquisition of Florida Chemical Company, Inc. (FCC) on the same date. The transaction involved a merger where FCC became a wholly-owned subsidiary of Flotek. The filing also details amendments to Flotek's credit facilities and the appointment of new leadership for the acquired entity.
Key Financial Metrics and Transaction Terms
- Merger Consideration: Total consideration for FCC stockholders consisted of 3,284,180 shares of Flotek common stock and $49,500,000 in cash, subject to customary working capital adjustments.
- Escrow Fund: An escrow fund of $10,000,000 was established to cover indemnification obligations, split equally between cash and Flotek common stock.
- Debt Facility Amendment:
- Term loan increased from $25 million to $50 million.
- Revolving credit availability increased to $75 million (including $10 million for letters of credit and $50 million for inventory).
- Term extended to May 10, 2018.
- Interest rate structure: 0.5% to 2.75% plus Alternate Base Rate or LIBOR.
- Financial Covenant: Maintain a consolidated EBITDA to debt ratio between 1.00 and 4.00.
- Principal payments required from Excess Cash Flow up to $3 million annually.
- Unregistered Securities: 3,284,180 shares of common stock were issued to FCC stockholders under Section 4(2) and Regulation D exemptions.
Material Changes
The primary material change is the expansion of Flotek's operations through the acquisition of FCC, a leading manufacturer of citrus oils. Concurrently, Flotek significantly increased its debt capacity and extended its credit facility maturity to support the transaction and future growth. The company also expanded its executive team with the appointment of Josh Snively as President of the newly renamed Florida Chemical Company, Inc.
Outlook, Risks, and Management Commentary
- Integration Risks: Management highlights risks related to integrating operations and personnel, potential diversion of management attention, and the assumption of undisclosed liabilities.
- Costs and Synergies: The company expects to incur substantial transaction and merger-related costs. There is no guarantee that expected synergies or benefits will be achieved in the near term or at all.
- Registration Rights: Flotek agreed to file a registration statement for the resale of the stock issued to FCC stockholders, with penalties for failure to meet filing deadlines.
- Forward-Looking Statements: The filing includes standard disclaimers that actual results may differ materially from projected outcomes due to various uncertainties.
Investor Verification Checklist
- Verify the final working capital adjustment amount to determine the exact cash and stock consideration paid.
- Review the full text of the Merger Agreement (Exhibit 2.1) for specific representations, warranties, and indemnification details.
- Confirm the impact of the new debt covenants (EBITDA to debt ratio) on Flotek's future financial flexibility.
- Monitor the timeline for the filing of the registration statement regarding the 3,284,180 unregistered shares issued to FCC stockholders.
- Assess the integration progress and actual transaction costs incurred in subsequent quarterly reports.